Sign In
Buy AVNS
$24.99
+0 (+0%)
At Close: Jul 31, 2026
AVANOS MEDICAL (AVNS) to Release Quarterly Earnings on Wednesday
03:00am, Wednesday, 22'nd Oct 2025
AVANOS MEDICAL (NYSE: AVNS - Get Free Report) will likely be announcing its Q3 2025 results before the market opens on Wednesday, October 29th. Analysts expect the company to announce earnings of $0.1
Avanos Medical: After Transformation Efforts, I Expect Inorganic Growth To Push The Price Up
03:28am, Sunday, 05'th Oct 2025
Avanos Medical is deeply undervalued, with strong international expansion, aggressive M&A strategy, and a new CFO poised to drive inorganic growth. AVNS operates in high-growth markets, maintains a so
Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio
09:45am, Thursday, 18'th Sep 2025
AVNS acquires Nexus Medical, adding its TKO connector to expand critical care offerings and drive immediate revenue and earnings growth.
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
01:36pm, Wednesday, 10'th Sep 2025
AVNS's solid Q2 performance, strong product demand, and strategic transformation support growth amid tariff and FX headwinds.
The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice
10:00am, Friday, 29'th Aug 2025
Avanos Medical, Inc. appears deeply undervalued after years of restructuring, with a potential stabilization in sales and earnings projected for 2025. Recent tariff impacts and lowered guidance seem f
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down
02:10pm, Wednesday, 06'th Aug 2025
AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.
Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript
01:26pm, Tuesday, 05'th Aug 2025
Avanos Medical, Inc. (NYSE:AVNS ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants David C. Pacitti - Chief Executive Officer Jason M.
Avanos Medical (AVNS) Q2 Revenue Up 2%
11:58am, Tuesday, 05'th Aug 2025
Avanos Medical (AVNS) Q2 Revenue Up 2%
Avanos Medical (AVNS) Misses Q2 Earnings Estimates
08:45am, Tuesday, 05'th Aug 2025
Avanos Medical (AVNS) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.34 per share a year ago.
ALPHARETTA, Ga. , Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its new senior vice preside
Avanos Medical, Inc. Announces Second Quarter 2025 Results
06:30am, Tuesday, 05'th Aug 2025
ALPHARETTA, Ga. , Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2025 financial results.
Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical
04:15pm, Thursday, 31'st Jul 2025
ALPHARETTA, Ga. , July 31, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to Channel-Markers Medical, LLC (CMM), a pr
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results
10:20am, Thursday, 24'th Jul 2025
ALPHARETTA, Ga. , July 24, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2025 on
New Strong Sell Stocks for July 15th
06:26am, Tuesday, 15'th Jul 2025
DDD, AVNS and BABA have been added to the Zacks Rank #5 (Strong Sell) List on July 15, 2025.
Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer
07:15am, Monday, 09'th Jun 2025
ALPHARETTA, Ga. , June 9, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a leading medical technology company focused on delivered innovative healthcare solutions, today announced the appoint
